STOCK TITAN

Oracle Life Sciences AI Agents Bring AI-Assisted Operational Intelligence and Coordination to Clinical Trials

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
AI

Oracle (ORCL) introduced Oracle Life Sciences AI Agents to help clinical trial teams spot operational issues and coordinate responses. The agents are available to early adopters and focus on portfolio monitoring, trial planning and trial conduct. They combine insights from Oracle Life Sciences applications and supported third-party data sources.

The agents are designed to monitor study performance, identify likely reasons why it differs from targets and recommend actions that follow the trial protocol. People review recommendations and approve proposed actions before execution. Oracle plans to extend the agents to clinical data management, post-trial analysis, trial design and post-market workflows, which cover work after a product reaches the market.

Loading...
Loading translation...

Key Terms

kpi, pharmacovigilance, real-world evidence
3 terms
kpi technical
"monitor study performance, likely drivers of KPI variances"
A KPI is a measurable metric a company tracks to show progress toward a specific business goal, such as sales growth, customer retention, profit margins, or production speed. Investors treat KPIs like a car’s dashboard: they reveal whether management is driving the company in the right direction, help compare companies on the same scale, and flag strengths or problems that could affect future returns.
pharmacovigilance medical
"clinical research and pharmacovigilance throughout the therapeutic development lifecycle"
Pharmacovigilance is the process of monitoring and assessing the safety of medicines after they are on the market, ensuring that any side effects or risks are identified and managed. For investors, it matters because it helps ensure that pharmaceutical companies maintain safe products, which can influence a company’s reputation, regulatory approval, and financial stability over time.
real-world evidence medical
"leveraging real-world evidence to deliver innovation"
Real-world evidence is information gathered from everyday sources like patient records, insurance claims, or everyday experiences, rather than controlled experiments or clinical trials. It helps investors understand how products or policies perform in real life, providing a more complete picture of their effectiveness and value beyond official tests. This type of evidence can influence decision-making by offering insights based on actual, everyday outcomes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

New AI-assisted experience supports portfolio visibility, helps identify operational risks, and recommends next best actions

AUSTIN, Texas, Nov. 18, 2026 /PRNewswire/ -- Oracle today introduced Oracle Life Sciences AI Agents, a new agentic experience designed to help life sciences organizations apply intelligence and AI-assisted coordination to enhance clinical trial operations. By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues, recommend appropriate actions for review and approval, and coordinate responses across clinical development workflows. For example, an agent can monitor study performance, likely drivers of KPI variances, and recommend operational actions that follow trial protocol.

Available today for early adopters, Oracle Life Sciences AI Agents focus on portfolio monitoring, trial planning, and trial conduct. Planned enhancements are intended to extend AI-assisted capabilities into clinical development domains, including clinical data management, post-trial analytics, trial design, and post-market workflows. The new AI Agents are designed to operate with human oversight, with humans responsible for reviewing recommendations and approving proposed actions before execution.

"Clinical development requires organizations to coordinate complex operational activity across studies, applications, data, and teams," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "We are bringing AI-assisted intelligence into clinical trial operations to help organizations to monitor performance, identify emerging risks, and coordinate responses across the trial lifecycle. By combining Oracle's Life Sciences applications, AI-assisted capabilities, connected data services, on a secure, scalable cloud infrastructure, we are helping organizations coordinate clinical research workflows and operational decisions across their clinical trial environments."

For more information about Life Sciences AI Agents and other Oracle Life Sciences solutions, visit: https://www.oracle.com/life-sciences/.

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in Oracle Cloud. For more information about Oracle (NYSE: ORCL), visit www.oracle.com.

Trademarks
Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-life-sciences-ai-agents-bring-ai-assisted-operational-intelligence-and-coordination-to-clinical-trials-302943185.html

SOURCE Oracle

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What do Oracle Life Sciences AI Agents do in clinical trials?

Oracle Life Sciences AI Agents are designed to flag operational issues and recommend responses for clinical trial teams. They draw on Oracle Life Sciences applications and supported third-party data sources, and people review recommendations and approve proposed actions before execution.

Who can use Oracle Life Sciences AI Agents now?

Oracle Life Sciences AI Agents are available to early adopters. The initial focus is on monitoring trial portfolios, planning trials and supporting trial conduct.

Keep reading